Category: Research
BA.2.75 designated a VUM by both WHO and ECDC *3 updates*
The World Health Organisation and the European Centre for Disease Control (ECDC) have designated Omicron subvariant BA.2.75 as a variant under monitoring (VUM). More...
Monkeypox: WHO reports 2 new deaths, 77% increase cases in 10 days
“Since the previous Disease Outbreak News was published on 27 June 2022, 2614 new cases, (77% increase) and two new deaths have been reported; nine new countries/territories/areas have reported cases.” More...
Monkeypox: Asymptomatic spread reported in Belgium
“The existence of asymptomatic monkeypox infection indicates that the virus might be transmitted to close contacts in the absence of symptoms. More...
Preprint: Mink can be infected by Omicron and efficiently transmit the virus to other mink
To study whether mink can transmit Omicron, we placed 2 uninfected indirect contact mink in separate cages 10–20 cm from the cages of the infected mink and followed their progress for 10 days. More...
Preprint: Bergamottin exhibits inhibitory activity against SARS-CoV-2
Here, we reported that bergamottin, a furanocoumarin originally found in bergamot, exhibited inhibitory activity against SARS-CoV-2 in vitro, ex vivo, and in vivo. More...
Preprint: More severe disorders in the lungs of BA.4/BA.5 infected hamsters than those of BA.2
“Here we demonstrated that the Omicron BA.4/5 are more potentially pathogenic than Omicron BA.2. More...
Italy: Lung function impaired by BA.5 infection
Subjects hospitalized for Omicron BA.5 showed an altered endothelial function three months after the acute phase with an impairment of lung function. More...
Monkeypox: Extensive surface contamination following treatment
Two new preprints just published shed light on possible transmission routes for the Monkeypox virus, in particular, on the possibility of surface contamination as a vector for infection. More...
Science Mag: SARS-CoV-2 already finding ways to evade Paxlovid
New lab studies shows that SARS-CoV-2 can mutate in ways that make it less susceptible to Paxlovid. More...
WHO: BA.5 now dominant globally
As of epidemiological week 24, BA.5 represents 43% of global sequences at Gisaid, BA.2 represents 25%, BA.4 represents 12%, and BA.2.12.1 represents 11%. More...